サマリー

市場分析と洞察。世界の眼内投与薬市場
COVID-19のパンデミックにより、眼内投与薬の世界市場規模は2022年に26590百万米ドルと推定され、2028年には35220百万米ドルに再調整されると予測されています（検討期間中のCAGRは4.8%）。この健康危機による経済的変化を十分に考慮した上で、2021年にOcular InsertがOcular Drug Deliveryの世界市場の%を占めていましたが、COVID-19後の期間にCAGRを修正して成長し、2028年には100万米ドルになると予測しています。一方、病院のセグメントは、この予測期間中、年率％で変化しています。
中国のOcular Drug Deliveryの市場規模は2021年に百万米ドル、米国と欧州のOcular Drug Deliveryはそれぞれ百万米ドルと百万米ドルとなっています。米国の割合は2021年には%ですが、中国と欧州はそれぞれ%と%で、中国の割合は2028年には%に達し、分析期間中のCAGRは%になると予測されています。アジアでは、日本、韓国、東南アジアが注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。欧州の眼内麻薬市場では、ドイツが2028年までに100万米ドルに達すると予測されています。
眼内ドラッグデリバリーの世界主要メーカーには、OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, EyeGate Pharma, Valeant Pharmaceuticals International, Inc, Envisia Therapeutics, Clearside Biomedical, Graybug Vision Inc, Taiwan Liposome Companyなどがあります。2021年には、世界の上位5社の売上高シェアは約%となっています。
世界の点眼薬市場の範囲とセグメント
Ocular Drug Delivery市場は、タイプ別、アプリケーション別に分類されています。世界のOcular Drug Delivery市場のプレーヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント分析では、2017年から2028年までのタイプ別、アプリケーション別の売上、収益、予測に焦点を当てています。
タイプ別セグメント
オキュラーインサート
イオントフォレーシス
眼内インプラント
インサイチュジェル＆パンクタルプラグ
その他
用途別セグメント
病院
外来手術センター
眼科医院
ホームケア施設
会社別
オキュラー・セラピューティック社（Ocular Therapeutix, Inc.
アリメラ・サイエンス
Allergan, Plc
アイゲート・ファーマ
Valeant Pharmaceuticals International, Inc.
エンビシア・セラピューティクス
クリアスサイド・バイオメディカル
グレイバグ・ビジョン社
台湾リポソーム社
参天製薬
地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.

ページTOPに戻る

目次

1 Study Coverage
1.1 Ocular Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Ocular Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Ocular Insert
1.2.3 Iontophoresis
1.2.4 Intraocular Implants
1.2.5 In Situ Gel & Punctal Plugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Ocular Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Ophthalmic Clinics
1.3.5 Homecare Settings
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ocular Drug Delivery Sales Estimates and Forecasts 2017-2028
2.2 Global Ocular Drug Delivery Revenue Estimates and Forecasts 2017-2028
2.3 Global Ocular Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Ocular Drug Delivery Sales by Region
2.4.1 Global Ocular Drug Delivery Sales by Region (2017-2022)
2.4.2 Global Sales Ocular Drug Delivery by Region (2023-2028)
2.5 Global Ocular Drug Delivery Revenue by Region
2.5.1 Global Ocular Drug Delivery Revenue by Region (2017-2022)
2.5.2 Global Ocular Drug Delivery Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Ocular Drug Delivery Sales by Manufacturers
3.1.1 Global Top Ocular Drug Delivery Manufacturers by Sales (2017-2022)
3.1.2 Global Ocular Drug Delivery Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ocular Drug Delivery in 2021
3.2 Global Ocular Drug Delivery Revenue by Manufacturers
3.2.1 Global Ocular Drug Delivery Revenue by Manufacturers (2017-2022)
3.2.2 Global Ocular Drug Delivery Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Ocular Drug Delivery Revenue in 2021
3.3 Global Ocular Drug Delivery Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Ocular Drug Delivery Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ocular Drug Delivery Sales by Type
4.1.1 Global Ocular Drug Delivery Historical Sales by Type (2017-2022)
4.1.2 Global Ocular Drug Delivery Forecasted Sales by Type (2023-2028)
4.1.3 Global Ocular Drug Delivery Sales Market Share by Type (2017-2028)
4.2 Global Ocular Drug Delivery Revenue by Type
4.2.1 Global Ocular Drug Delivery Historical Revenue by Type (2017-2022)
4.2.2 Global Ocular Drug Delivery Forecasted Revenue by Type (2023-2028)
4.2.3 Global Ocular Drug Delivery Revenue Market Share by Type (2017-2028)
4.3 Global Ocular Drug Delivery Price by Type
4.3.1 Global Ocular Drug Delivery Price by Type (2017-2022)
4.3.2 Global Ocular Drug Delivery Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Ocular Drug Delivery Sales by Application
5.1.1 Global Ocular Drug Delivery Historical Sales by Application (2017-2022)
5.1.2 Global Ocular Drug Delivery Forecasted Sales by Application (2023-2028)
5.1.3 Global Ocular Drug Delivery Sales Market Share by Application (2017-2028)
5.2 Global Ocular Drug Delivery Revenue by Application
5.2.1 Global Ocular Drug Delivery Historical Revenue by Application (2017-2022)
5.2.2 Global Ocular Drug Delivery Forecasted Revenue by Application (2023-2028)
5.2.3 Global Ocular Drug Delivery Revenue Market Share by Application (2017-2028)
5.3 Global Ocular Drug Delivery Price by Application
5.3.1 Global Ocular Drug Delivery Price by Application (2017-2022)
5.3.2 Global Ocular Drug Delivery Price Forecast by Application (2023-2028)
6 North America
6.1 North America Ocular Drug Delivery Market Size by Type
6.1.1 North America Ocular Drug Delivery Sales by Type (2017-2028)
6.1.2 North America Ocular Drug Delivery Revenue by Type (2017-2028)
6.2 North America Ocular Drug Delivery Market Size by Application
6.2.1 North America Ocular Drug Delivery Sales by Application (2017-2028)
6.2.2 North America Ocular Drug Delivery Revenue by Application (2017-2028)
6.3 North America Ocular Drug Delivery Market Size by Country
6.3.1 North America Ocular Drug Delivery Sales by Country (2017-2028)
6.3.2 North America Ocular Drug Delivery Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Ocular Drug Delivery Market Size by Type
7.1.1 Europe Ocular Drug Delivery Sales by Type (2017-2028)
7.1.2 Europe Ocular Drug Delivery Revenue by Type (2017-2028)
7.2 Europe Ocular Drug Delivery Market Size by Application
7.2.1 Europe Ocular Drug Delivery Sales by Application (2017-2028)
7.2.2 Europe Ocular Drug Delivery Revenue by Application (2017-2028)
7.3 Europe Ocular Drug Delivery Market Size by Country
7.3.1 Europe Ocular Drug Delivery Sales by Country (2017-2028)
7.3.2 Europe Ocular Drug Delivery Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Ocular Drug Delivery Market Size by Type
8.1.1 Asia Pacific Ocular Drug Delivery Sales by Type (2017-2028)
8.1.2 Asia Pacific Ocular Drug Delivery Revenue by Type (2017-2028)
8.2 Asia Pacific Ocular Drug Delivery Market Size by Application
8.2.1 Asia Pacific Ocular Drug Delivery Sales by Application (2017-2028)
8.2.2 Asia Pacific Ocular Drug Delivery Revenue by Application (2017-2028)
8.3 Asia Pacific Ocular Drug Delivery Market Size by Region
8.3.1 Asia Pacific Ocular Drug Delivery Sales by Region (2017-2028)
8.3.2 Asia Pacific Ocular Drug Delivery Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Ocular Drug Delivery Market Size by Type
9.1.1 Latin America Ocular Drug Delivery Sales by Type (2017-2028)
9.1.2 Latin America Ocular Drug Delivery Revenue by Type (2017-2028)
9.2 Latin America Ocular Drug Delivery Market Size by Application
9.2.1 Latin America Ocular Drug Delivery Sales by Application (2017-2028)
9.2.2 Latin America Ocular Drug Delivery Revenue by Application (2017-2028)
9.3 Latin America Ocular Drug Delivery Market Size by Country
9.3.1 Latin America Ocular Drug Delivery Sales by Country (2017-2028)
9.3.2 Latin America Ocular Drug Delivery Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Ocular Drug Delivery Market Size by Type
10.1.1 Middle East and Africa Ocular Drug Delivery Sales by Type (2017-2028)
10.1.2 Middle East and Africa Ocular Drug Delivery Revenue by Type (2017-2028)
10.2 Middle East and Africa Ocular Drug Delivery Market Size by Application
10.2.1 Middle East and Africa Ocular Drug Delivery Sales by Application (2017-2028)
10.2.2 Middle East and Africa Ocular Drug Delivery Revenue by Application (2017-2028)
10.3 Middle East and Africa Ocular Drug Delivery Market Size by Country
10.3.1 Middle East and Africa Ocular Drug Delivery Sales by Country (2017-2028)
10.3.2 Middle East and Africa Ocular Drug Delivery Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 OCULAR THERAPEUTIX, INC
11.1.1 OCULAR THERAPEUTIX, INC Corporation Information
11.1.2 OCULAR THERAPEUTIX, INC Overview
11.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 OCULAR THERAPEUTIX, INC Recent Developments
11.2 Alimera Sciences
11.2.1 Alimera Sciences Corporation Information
11.2.2 Alimera Sciences Overview
11.2.3 Alimera Sciences Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Alimera Sciences Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Alimera Sciences Recent Developments
11.3 Allergan, Plc
11.3.1 Allergan, Plc Corporation Information
11.3.2 Allergan, Plc Overview
11.3.3 Allergan, Plc Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Allergan, Plc Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Allergan, Plc Recent Developments
11.4 EyeGate Pharma
11.4.1 EyeGate Pharma Corporation Information
11.4.2 EyeGate Pharma Overview
11.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 EyeGate Pharma Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 EyeGate Pharma Recent Developments
11.5 Valeant Pharmaceuticals International, Inc
11.5.1 Valeant Pharmaceuticals International, Inc Corporation Information
11.5.2 Valeant Pharmaceuticals International, Inc Overview
11.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Valeant Pharmaceuticals International, Inc Recent Developments
11.6 Envisia Therapeutics
11.6.1 Envisia Therapeutics Corporation Information
11.6.2 Envisia Therapeutics Overview
11.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Envisia Therapeutics Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Envisia Therapeutics Recent Developments
11.7 Clearside Biomedical
11.7.1 Clearside Biomedical Corporation Information
11.7.2 Clearside Biomedical Overview
11.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Clearside Biomedical Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Clearside Biomedical Recent Developments
11.8 Graybug Vision Inc
11.8.1 Graybug Vision Inc Corporation Information
11.8.2 Graybug Vision Inc Overview
11.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Graybug Vision Inc Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Graybug Vision Inc Recent Developments
11.9 Taiwan Liposome Company
11.9.1 Taiwan Liposome Company Corporation Information
11.9.2 Taiwan Liposome Company Overview
11.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Taiwan Liposome Company Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Taiwan Liposome Company Recent Developments
11.10 Santen Pharmaceutical
11.10.1 Santen Pharmaceutical Corporation Information
11.10.2 Santen Pharmaceutical Overview
11.10.3 Santen Pharmaceutical Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Santen Pharmaceutical Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Santen Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ocular Drug Delivery Industry Chain Analysis
12.2 Ocular Drug Delivery Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ocular Drug Delivery Production Mode & Process
12.4 Ocular Drug Delivery Sales and Marketing
12.4.1 Ocular Drug Delivery Sales Channels
12.4.2 Ocular Drug Delivery Distributors
12.5 Ocular Drug Delivery Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Ocular Drug Delivery Industry Trends
13.2 Ocular Drug Delivery Market Drivers
13.3 Ocular Drug Delivery Market Challenges
13.4 Ocular Drug Delivery Market Restraints
14 Key Findings in The Global Ocular Drug Delivery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer